4//SEC Filing
Boenisch Sandra 4
Accession 0001731122-21-000012
CIK 0001314052other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 2:26 PM ET
Size
5.4 KB
Accession
0001731122-21-000012
Insider Transaction Report
Form 4
Boenisch Sandra
PFO & Treasurer
Transactions
- Award
Stock Option (Right to Buy)
2020-12-30+50,000→ 50,000 totalExercise: $5.49Exp: 2030-12-30→ Common stock (50,000 underlying)
Footnotes (1)
- [F1]The options shall vest upon the achievement of a certain clinical trial milestone with respect to the Issuer's Phase 2/3 clinical trial program of Anavex(R)2-73 for the treatment of Rett syndrome.
Documents
Issuer
ANAVEX LIFE SCIENCES CORP.
CIK 0001314052
Entity typeother
Related Parties
1- filerCIK 0001655366
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 2:26 PM ET
- Size
- 5.4 KB